A study has confirmed the effectiveness of a drug that can treat acquired genetic hearing loss. On the 11th, a research team led by Professor Ji Heon-young, Professor Jang Seung-hyun of Yonsei ...

Stuart S. Martin, PhD, an internationally recognized breast cancer researcher, has been appointed Chair of the University of Maryland School of Medicine (UMSOM) Department of Pharmacology & Physiology ...

Approved JAK inhibitors such as ruxolitinib and fedratinib target the JH1 kinase domain, offering symptomatic relief but lacking selectivity for the mutant form. This non-selective inhibition disrupts ...

Valparaiso University’s physician assistant students stepped into the human heart through virtual reality technology.

Ratutrelvir, a ritonavir-free Main protease (Mpro/3CL) inhibitor, was discovered and developed ab initio from target to clinic by ChemDiv's medicinal chemistry and virology services teams. Leveraging ...

Detailed price information for Neumora Therapeutics Inc (NMRA-Q) from The Globe and Mail including charting and trades.

Nitazenes, a class of synthetic drugs 40 times more potent than fentanyl, are steadily becoming more common on both sides of ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...

The awards were made possible by ongoing support from the Blavatnik Family Foundation that aims to spur scientific ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel ...

The significant reduction in the use of animal models for teaching at UK universities is creating a skills shortage among ...